HAUSMAN DIANA

ZNTL

HAUSMAN DIANA serves as Director at Zentalis Pharmaceuticals, Inc. (ZNTL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$19.9K

Total Sells

1 trades

$42.4K

Net Position

Net Seller

$22.5K

Companies Traded

IMRX, ZNTL

Active Period

May 2024 – Jul 2025

2 total trades

Most Recent

Buy IMRX

Jul 2, 2025 · $19.9K

HAUSMAN DIANA's Insider Trading at Zentalis Pharmaceuticals, Inc. (ZNTL)

Buys

0 · $0.00

Sells

1 · $42.4K

Total Shares Bought

Total Shares Sold

3,356

ZNTL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 9, 2024	Sell	3,356	$12.62	$42.4K	373,876

HAUSMAN DIANA's Insider Trading at Immuneering Corporation (IMRX)

Buys

1 · $19.9K

Sells

0 · $0.00

Total Shares Bought

5,500

Total Shares Sold

IMRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 2, 2025	Buy	5,500	$3.61	$19.9K	0

Related Insiders

Vultaggio Vincent

PAO and PFO

ZNTLSell · Feb 10, 2026

Ingmar Bruns

officer: Chief Medical Officer

ZNTLSell · Feb 10, 2026

EASTLAND JULIA MARIE

director, officer: CEO & President

ZNTLSell · Feb 10, 2026

Thomas J. Schall

Director

IMRXBuy · Jan 20, 2026

Harold Eugene Brakewood

Chief Business Officer

IMRXBuy · Jan 16, 2026

Leah R Neufeld

officer: CHIEF PEOPLE OFFICER

IMRXBuy · Jan 15, 2026

Brett Matthew Hall

CHIEF SCIENTIFIC OFFICER

IMRXBuy · Jan 15, 2026

Peter Feinberg

Director

IMRXBuy · Jan 14, 2026

Explore More Insider Trading Data

ZNTL Insider Trading Activity

View all insider trades at Zentalis Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity